McNeil, producer of over-the-counter drugs like Tylenol and Benadryl, has issued yet another recall due to a musty odor associated with packaging.
The most recent in a series of over-the-counter drug recalls is now Tylenol 8-hour caplets 50 count. Numerous complaints about the odor of these particular packages, which are sold in the United States and Puerto Rico, are what led to the recall by McNeil, despite the company saying that “the risk of adverse medical events is remote.”
An estimated 128,000 bottles will be recalled, the lot of which was made in March at a factory in Fort Washington, Pennsylvania. The most recent recall for McNeil adds to a laundry list of recalls that have added up to tens of millions of bottles, all within the past year. Because of the numerous recalls, McNeil now faces a US congressional probe of quality control lapses.
Reuters reports that the FDA “cited thick dust, grime and contaminated ingredients at the Fort Washington plant. J&J plans to reopen the plant next year, and is using other McNeil plants to help offset lost production of the recalled products.”
Although a recall is obviously never a good thing for a company, this is an especially bad time for McNeil, as the company is scheduled to report third quarter earnings today.
Around the Web
Musty odor sparks another Tylenol recall [Reuters]
More Trouble With Tylenol [NY Times]
That Familiar Musty Odor Hits J&J Again [WSJ]